Navigation Links
Paragon Bioservices Wins CMO Leadership Awards for Third Consecutive Year
Date:9/10/2013

BALTIMORE, Sept. 10, 2013 /PRNewswire/ -- Paragon Bioservices, a contract manufacturing organization whose expertise is the process development and manufacturing of biopharmaceuticals, announced today that it has been awarded the 2013 CMO Leadership Award for Quality and Reliability.

"We are very honored to receive this award from Life Science Leader -- especially because this is our third consecutive year," said Dr Marco Chacon, Paragon's CEO. "For more than twenty years, we have helped pharmaceutical and biotechnology companies and government agencies move forward in the development and manufacturing of vaccines (VLPs), monoclonal antibodies and therapeutic proteins.  We've completed two expansions in the past 4 years in order to constantly improve these capabilities.  Therefore, customer service, quality and reliability truly are key areas of focus at Paragon Bioservices.  The fact that we were recognized in the top 20% by more than 10,000 pharmaceutical executives is extremely gratifying to all of us at Paragon."

According to Jon Howland, Vice President of Publishing at Life Science Leader magazine, "These awards were conceived to better serve pharmaceutical and biopharmaceutical executives in their vetting process.  It gives them information on what their peers think of a wide range of CMOs and helps them to ultimately identify the leading CMOs in the industry."

ABOUT PARAGON BIOSERVICES, INC.
Paragon is a Contract Research & GMP Manufacturing Organization (CMO) delivering research, process development and manufacturing services. Paragon's focus is biopharmaceuticals -- including recombinant proteins, viral vectors, vaccines, VLPs, and bacteriophage. Our clients include pharmaceutical companies, biotechnology companies and federal agencies.  Our GMP space includes microbial and mammalian suites, fill-finish, and fully-segregated virus and BSL-3 facilities.

ABOUT LIFE SCIENCE LEADER
The vision of Life Science Leader is to be an essential business tool for life science executives. We are focused on staying connected with the key players and topics in the life science industry and making our magazine a must-read for our executive-level audience.  These CMO Leadership Awards are based on industry research and market intelligence conducted by Nice Insight -- a business that conducts the industry's largest annual outsourcing survey. 

MEDIA CONTACT:

Debbie James
Executive Vice President
Paragon Bioservices, Inc.
djames@paragonbioservices.com
(410)975-4050

 


'/>"/>
SOURCE Paragon Bioservices, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Bausch + Lomb Signs Exclusive License Agreement with Paragon BioTeck for Phenylephrine
2. Biotechnology Market (Biopharmacy, Bioservices, Bioagri, Bioindustrial) Is Expected to Reach USD 414.5 Billion Globally in 2017: Transparency Market Research
3. Fisher BioServices Intensifies Commitment for Cell Therapy Companies in Clinical Trials and Approaching Commercialization
4. Nabsys Expands Leadership Team to Prepare for Commercialization of Novel DNA Positional Sequencing Technology
5. Berkeley Lab seeks to help US assert scientific leadership in critical materials
6. Auxilium Announces Appointments to Enhance Leadership Team
7. More than half of Americans doubt US global leadership in 2020
8. USC Marshall School of Business 6th Annual Leadership Summit
9. Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory Board
10. BioMotiv Launches Novel Drug Development Operation, Names Leadership Team
11. Innovation Leaders from Across Industries will Convene to Share Best Practices and Breakthrough Successes at Open Innovation Leadership Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... 2017 Interpace Diagnostics Group, Inc. (NASDAQ: ... clinically useful molecular diagnostic tests and pathology services, ... securities purchase agreement with three  institutional investors to ... stock in a registered direct offering.  In a ... sell to the same investors warrants to purchase ...
(Date:1/21/2017)... , Jan. 20, 2017 Aratana Therapeutics, ... company focused on the licensing, development and commercialization of ... Pharm,s Best Company in North America ... the award based on the FDA approval ... (grapiprant tablets), ENTYCE ® (capromorelin oral solution) and ...
(Date:1/20/2017)... ... , ... The two newest companies to join the University City Science Center’s ... from The Wistar Institute, and Sanguis, launched by a trio of students from the ... Vironika is developing a treatment for a chronic viral infection and its associated diseases, ...
(Date:1/20/2017)... Ginkgo Bioworks, the organism company, announced ... the synthesis and assembly of DNA. The acquisition ... synthetic DNA into Ginkgo,s automated organism engineering foundries, ... of new organism designs for application across a ... founded to significantly increase the world,s capacity to ...
Breaking Biology Technology:
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL ... desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar ... 2017, con múltiples sitios previstos a lo largo de Europa y ... MSC-1 es ... inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ...
(Date:12/15/2016)...   WaferGen Bio-systems, Inc. (NASDAQ: ... today that on December 13, 2016, it received a ... Stock Market LLC which acknowledged that, as of December ... stock had been at $1.00 or greater for ten ... Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/12/2016)...  Researchers at Trinity College, Dublin, are opening ... the material with Silly Putty. The mixture (known as ... to sense pulse, blood pressure, respiration, and even ... The research team,s findings were published Thursday ... http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):